Role of PKC-ERK signaling in tamoxifen-induced apoptosis and tamoxifen resistance in human breast cancer cells.

This study was designed to investigate the role of protein kinase C (PKC) and extracellular signal-regulated kinase 1/2 (ERK1/2) signaling in tamoxifen (TAM)-induced apoptosis and drug resistance in human breast cancer cells. Drug-sensitive, or estrogen receptor (ER)-positive human breast carcinoma cells (MCF-7) and the multi-drug-resistant variant (ER-negative) MCF-7/ADR cells were treated with doses of TAM for various periods of time. Cell viability and apoptosis were assessed using cell counting, DNA fragmentation and flow cytometric analysis. We found that TAM administration caused a significant increase in apoptosis of MCF-7 cells but not MCF-7/ADR cells. Western blot analysis revealed enhanced expression of PKCδ but decreased expression of PKCα in ER-positive MCF-7 cells; while ER-negative MCF-7/ADR cells had decreased levels of PKCδ and increased levels of PKCα. Interestingly, we observed that in MCF-7 cells, TAM stimulated apoptosis by promoting rapid activation of PKCδ, antagonizing downstream signaling of ERK phosphorylation; while in MCF-7/ADR cells, TAM upregulated PKCα, which promoted ERK phosphorylation. These results suggest that PKCδ enhances apoptosis in TAM-treated MCF-7 cells by antagonizing ERK phosphorylation; while the PKCα pathway plays an important role in TAM-induced drug resistance by activating ERK signaling in MCF-7/ADR cells. The combination of TAM with PKCα and ERK inhibitors could promote TAM-induced apoptosis in breast cancer cells.

[1]  K. Reddy,et al.  Mitogen‐activated protein kinase (MAPK) regulates the expression of progelatinase B (MMP‐9) in breast epithelial cells , 1999, International journal of cancer.

[2]  W. Bollag.  Protein kinase Calpha puts the hand cuffs on epidermal keratinocyte proliferation. , 2009, The Journal of investigative dermatology.

[3]  H. Hug,et al.  Protein kinase C isoenzymes: divergence in signal transduction? , 1993, The Biochemical journal.

[4]  M. Cobb,et al.  Extracellular signal-regulated kinases in T cells. Anti-CD3 and 4 beta-phorbol 12-myristate 13-acetate-induced phosphorylation and activation. , 1992, Journal of immunology.

[5]  G. King,et al.  Identification of PKC-isoform-specific biological actions using pharmacological approaches. , 2000, Trends in pharmacological sciences.

[6]  Zhihua Li,et al.  Activated PKCα/ERK1/2 Signaling Inhibits Tamoxifen-Induced Apoptosis in C6 Cells , 2009, Cancer investigation.

[7]  J. Frost,et al.  A requirement for extracellular signal-regulated kinase (ERK) function in the activation of AP-1 by Ha-Ras, phorbol 12-myristate 13-acetate, and serum. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[8]  M. Crépin,et al.  FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. , 2002, Biochemical and biophysical research communications.

[9]  J. Stenvang,et al.  Protein Kinase C alpha is a marker for antiestrogen resistance and is involved in the growth of tamoxifen resistant human breast cancer cells. , 2007, Breast cancer research and treatment.

[10]  Patrizia Agostinis,et al.  Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. , 2007, Biochimica et biophysica acta.

[11]  K. Reddy,et al.  Distinct mechanisms mediate the initial and sustained phases of cell migration in epidermal growth factor receptor-overexpressing cells. , 2003, Molecular cancer research : MCR.

[12]  Michael E. Greenberg,et al.  Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis , 1995, Science.

[13]  V. Jordan,et al.  Stable transfection of protein kinase C alpha cDNA in hormone-dependent breast cancer cell lines , 2000, British Journal of Cancer.

[14]  D. Fabbro,et al.  Selective regulation of expression of protein kinase C (PKC) isoenzymes in multidrug-resistant MCF-7 cells. Functional significance of enhanced expression of PKC alpha. , 1993, The Journal of biological chemistry.

[15]  V. Jordan,et al.  Selective estrogen receptor modulation: concept and consequences in cancer. , 2004, Cancer cell.

[16]  D. Rose,et al.  Protein kinase C and its isoforms in human breast cancer cells: relationship to the invasive phenotype. , 1998, International journal of oncology.

[17]  R. Yu,et al.  Activation of Signal Transduction Kinases by Tamoxifen , 1997, Pharmaceutical Research.

[18]  V. Keshamouni,et al.  Mechanism of 17-beta-estradiol-induced Erk1/2 activation in breast cancer cells. A role for HER2 AND PKC-delta. , 2002, The Journal of biological chemistry.

[19]  S. Mandlekar,et al.  Mechanisms of tamoxifen-induced apoptosis , 2001, Apoptosis.

[20]  J. Pouysségur,et al.  Mitogen-activated protein kinases p42mapk and p44mapk are required for fibroblast proliferation. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[21]  S. Marsigliante,et al.  Protein kinase C (PKC)-δ/-ε mediate the PKC/Akt-dependent phosphorylation of extracellular signal-regulated kinases 1 and 2 in MCF-7 cells stimulated by bradykinin , 2006 .

[22]  Xiu-fen Lei,et al.  Abrogation of TGFβ Signaling Induces Apoptosis Through the Modulation of MAP Kinase Pathways in Breast Cancer Cells , 2007 .

[23]  L. Carpenter,et al.  Inhibition of PKCα induces a PKCδ-dependent apoptotic program in salivary epithelial cells , 2003, Cell Death and Differentiation.

[24]  Rakesh Kumar,et al.  Signaling regulation of genomic and nongenomic functions of estrogen receptors. , 2006, Cancer letters.

[25]  P. Dennis,et al.  Altered protein kinase C (PKC) isoforms in non-small cell lung cancer cells: PKCdelta promotes cellular survival and chemotherapeutic resistance. , 2003, Cancer research.

[26]  I. Weinstein,et al.  Effects of regulatory domains of specific isoforms of protein kinase C on growth control and apoptosis in MCF-7 breast cancer cells. , 2003, Journal of experimental therapeutics & oncology.

[27]  F. Umansky,et al.  Protein Kinase Cα and Protein Kinase Cδ Play Opposite Roles in the Proliferation and Apoptosis of Glioma Cells , 2001 .

[28]  Donald P. McDonnell,et al.  Connections and Regulation of the Human Estrogen Receptor , 2002, Science.

[29]  C. Peyssonnaux,et al.  The Raf/MEK/ERK pathway: new concepts of activation , 2001, Biology of the cell.

[30]  Y. Kaufmann,et al.  Tamoxifen and raloxifene suppress the proliferation of estrogen receptor-negative cells through inhibition of glutamine uptake , 2011, Cancer Chemotherapy and Pharmacology.

[31]  M. Clemens,et al.  The role of protein kinase C isoenzymes in the regulation of cell proliferation and differentiation. , 1992, Journal of cell science.

[32]  Alan D. Lopez,et al.  Global and regional estimates of cancer mortality and incidence by site: II. results for the global burden of disease 2000 , 2002, BMC Cancer.

[33]  B. G. Sanders,et al.  Tocotrienols induce apoptosis in breast cancer cell lines via an endoplasmic reticulum stress-dependent increase in extrinsic death receptor signaling , 2010, Breast Cancer Research and Treatment.

[34]  J. Cuzick,et al.  Response and resistance to the endocrine prevention of breast cancer. , 2008, Advances in experimental medicine and biology.

[35]  R. Park,et al.  Overexpression of protein kinase C isoforms protects RAW 264.7 macrophages from nitric oxide-induced apoptosis: involvement of c-Jun N-terminal kinase/stress-activated protein kinase, p38 kinase, and CPP-32 protease pathways. , 1999, Journal of immunology.

[36]  Y. Sugimoto,et al.  Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein , 2007, Molecular Cancer Therapeutics.

[37]  Huitu Liu,et al.  MAPK signal pathways in the regulation of cell proliferation in mammalian cells , 2002, Cell Research.

[38]  A. López-Rivas,et al.  Protein kinase C inhibits CD95 (Fas/APO-1)-mediated apoptosis by at least two different mechanisms in Jurkat T cells. , 1999, Journal of immunology.

[39]  M. Kazanietz,et al.  Protein kinase C delta enhances proliferation and survival of murine mammary cells. , 2007, Molecular carcinogenesis.

[40]  D. Vaux,et al.  Apoptosis in the development and treatment of cancer. , 2004, Carcinogenesis.

[41]  D. Bentrem,et al.  A mechanism of drug resistance to tamoxifen in breast cancer , 2002, The Journal of Steroid Biochemistry and Molecular Biology.

[42]  Wu Wen-sheng,et al.  Activation of protein kinase C alpha is required for TPA-triggered ERK (MAPK) signaling and growth inhibition of human hepatoma cell HepG2. , 2005, Journal of biomedical science.

[43]  S. Shen,et al.  IGF‐I plus E2 induces proliferation via activation of ROS‐dependent ERKs and JNKs in human breast carcinoma cells , 2007, Journal of cellular physiology.

[44]  Teruhiko Fujii,et al.  Protein Kinase C Promotes Apoptosis in LNCaP Prostate Cancer Cells through Activation of p38 MAPK and Inhibition of the Akt Survival Pathway* , 2003, Journal of Biological Chemistry.

[45]  R. Flavell,et al.  JunD mediates survival signaling by the JNK signal transduction pathway. , 2003, Molecular cell.

[46]  A. Newton,et al.  Protein Kinase C: Structure, Function, and Regulation (*) , 1995, The Journal of Biological Chemistry.

[47]  M. Pagano,et al.  Immediate and transient stimulation of protein tyrosine phosphorylation by estradiol in MCF-7 cells. , 1993, Oncogene.

[48]  Chi-Ying F. Huang,et al.  Mitochondrial anchoring of PKCα by PICK1 confers resistance to etoposide-induced apoptosis , 2007, Apoptosis.

[49]  R. Boland,et al.  Antisense oligonucleotides targeted against protein kinase c α inhibit proliferation of cultured avian myoblasts , 2000, Cell proliferation.

[50]  Ying Yan,et al.  BRCA1-induced Apoptosis Involves Inactivation of ERK1/2 Activities* , 2002, The Journal of Biological Chemistry.

[51]  P. Härkönen,et al.  Tamoxifen-induced rapid death of MCF-7 breast cancer cells is mediated via extracellularly signal-regulated kinase signaling and can be abrogated by estrogen. , 2007, Endocrinology.

[52]  Jiahuai Han,et al.  Activation and signaling of the p38 MAP kinase pathway , 2005, Cell Research.

[53]  Qingbo Xu,et al.  Cyclic Strain Stress-induced Mitogen-activated Protein Kinase (MAPK) Phosphatase 1 Expression in Vascular Smooth Muscle Cells Is Regulated by Ras/Rac-MAPK Pathways* , 1999, The Journal of Biological Chemistry.

[54]  R. Schiff,et al.  Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. , 2004, Journal of the National Cancer Institute.

[55]  P. Parker,et al.  MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype. , 1995, The Journal of clinical investigation.

[56]  E. Maizels,et al.  Regulation of protein kinase C delta by estrogen in the MCF-7 human breast cancer cell line. , 1999, Molecular and cellular endocrinology.

[57]  G. Leclercq,et al.  A ferrocenyl derivative of hydroxytamoxifen elicits an estrogen receptor-independent mechanism of action in breast cancer cell lines. , 2010, Journal of inorganic biochemistry.

[58]  L. Miraglia,et al.  Protein kinase C delta is a prosurvival factor in human breast tumor cell lines. , 2003, Molecular cancer therapeutics.

[59]  Dongxiao Sun,et al.  Potential Role of UGT Pharmacogenetics in Cancer Treatment and Prevention , 2009, Annals of the New York Academy of Sciences.